Skip to main content
OpenTrials
Completed

NCT Number: NCT04275934

Blood Pressure First Medication Therapy Management

The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hypertension Blood Pressure Cardiovascular Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Woodstock Pharmaceutical & Compounding Center Inc.

Woodstock, Georgia, 30188, United States

About this study

Univariate comparisons of the baseline/pre-intervention outcomes to the post-intervention outcomes will be performed on outcomes in order to determine how the intervention affects each. For continuous outcomes data the univariate comparisons of the pre-treatment and post-intervention outcomes will be performed using related samples t-test comparisons. For categorical outcomes data, comparisons of pre-intervention to post-intervention time frames will be performed using McNemar tests.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All health plan beneficiaries 18 years-of-age and older
  • Have filled at least one blood pressure medication in the last three months,
  • Have a known hypertension diagnosis or have an uncontrolled blood pressure

Exclusion criteria

  • Not an adult
  • Not a health plan beneficiary of the self-insured employer
  • Not ambulatory and able to work or participate in care visits

Treatment and study plan

Health Management; Blood Pressure

Behavioral

Pharmacists will work with the patient/study subject, referred to as the participant hereafter, and the participant's other health care providers to manage their blood pressure, making recommendations for medication and lifestyle adjustments as needed.

Primary outcomes

  1. Blood Pressure Control

    Time frame: 6-months

    Management of Systolic and Diastolic Blood Pressure Measures

  2. Blood Pressure Change

    Time frame: 6-months

    Systolic and Diastolic Blood Pressure Measure Changes

Secondary outcomes

  1. Blood Pressure Medication Adherence

    Time frame: 6-months

    Medication Adherence for Blood Pressure Medications as Measured by Proportion of Days Covered (PDC)

  2. Health Care Utilization of Primary Care Services

    Time frame: 6-months

    Evaluation of Pre- and Post-Intervention Frequency of Primary Health Care Visits

  3. Health Care Utilization of Emergency Department Services

    Time frame: 6-months

    Evaluation of Pre- and Post-Intervention Frequency Emergency Department Visits

  4. Health Care Utilization of Hospital Services

    Time frame: 6-months

    Evaluation of Pre- and Post-Intervention Frequency of Hospital Visits

Sponsors and collaborators

Lead sponsor

American Pharmacists Association Foundation

Other

Registry information

Official study title

Evaluation of the Impact of Self-insured Employer Implementation of an Innovative Care Model Utilizing Pharmacist-delivered MTM Services for Health Plan Beneficiaries With High Blood Pressure

Acronym: BP First

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Feb 19, 2020
Registry last updated
Feb 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.